A gene therapy preserves organ function and boosts life expectancy in mice, while base editing avoids some CRISPR damage in human embryos, and immune clues emerge for CAR T in glioblastoma
The Medicine Maker
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.